These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 23261898)

  • 21. Neuroleptic malignant syndrome.
    Ingall TJ; Tennant C
    Med J Aust; 1986 Nov; 145(9):454-5. PubMed ID: 3773831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neuroleptic malignant syndrome and related conditions].
    Amore M; Montanari M
    Minerva Psichiatr; 1992; 33(4):259-83. PubMed ID: 1363674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Differential diagnosis of malignant hyperthermia, febrile catatonia and neuroleptic malignant syndrome. A case comparison].
    Schröder J; Linge C; Wähner A
    Fortschr Neurol Psychiatr; 1988 Mar; 56(3):97-101. PubMed ID: 2896144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Malignant neuroleptic syndrome and malignant hyperthermia--a comparison].
    Spiess-Kiefer C; Hippius H
    Fortschr Neurol Psychiatr; 1986 May; 54(5):158-70. PubMed ID: 2426164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroleptic malignant syndrome versus malignant hyperthermia.
    Hard C
    Am J Med; 1991 Sep; 91(3):322-3. PubMed ID: 1892158
    [No Abstract]   [Full Text] [Related]  

  • 26. Neuroleptic malignant syndrome and serotonin syndrome in the critical care setting: case analysis.
    Kaufman KR; Levitt MJ; Schiltz JF; Sunderram J
    Ann Clin Psychiatry; 2006; 18(3):201-4. PubMed ID: 16923659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug resistant neuroleptic malignant syndrome and the role of electroconvulsive therapy.
    Hashim H; Zeb-un-Nisa ; Alrukn SA; Al Madani AA
    J Pak Med Assoc; 2014 Apr; 64(4):471-3. PubMed ID: 24864649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute Presentation of Nonmotor Symptoms in Parkinson's Disease.
    Kwei K; Frucht S
    Int Rev Neurobiol; 2017; 134():973-986. PubMed ID: 28805591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
    Khouri C; Planès S; Logerot S; Villier C; Mallaret M
    Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroleptic malignant syndrome. Recognition, prevention and management.
    Velamoor VR
    Drug Saf; 1998 Jul; 19(1):73-82. PubMed ID: 9673859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hyperthermia caused by drug interactions and adverse reactions.
    Paden MS; Franjic L; Halcomb SE
    Emerg Med Clin North Am; 2013 Nov; 31(4):1035-44. PubMed ID: 24176477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Malignant syndromes: current advances.
    Tao M; Li J; Wang X; Tian X
    Expert Opin Drug Saf; 2021 Sep; 20(9):1075-1085. PubMed ID: 33866917
    [No Abstract]   [Full Text] [Related]  

  • 33. A hazardous side effect of neuroleptics: diagnosis and treatment.
    Epperly TD; McGlaughlin VG; Leo KU
    Geriatrics; 1990 Aug; 45(8):58-62. PubMed ID: 1974232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myoglobinuria, malignant hyperthermia, neuroleptic malignant syndrome and serotonin syndrome.
    Bertorini TE
    Neurol Clin; 1997 Aug; 15(3):649-71. PubMed ID: 9227957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroleptic malignant syndrome due to olanzapine.
    Hall KL; Taylor WH; Ware MR
    Psychopharmacol Bull; 2001; 35(3):49-54. PubMed ID: 12397878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroleptic malignant syndrome.
    Levenson JL
    Am J Psychiatry; 1985 Oct; 142(10):1137-45. PubMed ID: 2863986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroleptic Malignant Syndrome.
    Pileggi DJ; Cook AM
    Ann Pharmacother; 2016 Nov; 50(11):973-981. PubMed ID: 27423483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neuroleptic malignant syndrome. Case reports].
    Berardi D; Troia M; Veronesi L; Ferrari G
    Minerva Psichiatr; 1994 Dec; 35(4):199-219. PubMed ID: 7861943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis and treatment of neuroleptic malignant syndrome.
    Guerrero RM; Shifrar KA
    Clin Pharm; 1988 Sep; 7(9):697-701. PubMed ID: 3240662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroleptic malignant syndrome.
    McHugh TP
    J S C Med Assoc; 1992 Jun; 88(6):303-6. PubMed ID: 1352559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.